D-Wave Quantum Sells $150 Million in Stock. It Isn’t the Only One Seizing the Opportunity.
Quantum Computing said earlier this month that it entered agreements to sell $100 million of common stock to institutional ...
Meta Stock Had a Great 2024. These Analysts Are Still Upbeat.
Meta Platforms had a stellar 2024 and BofA Securities sees further upside. Analysts Justin Post and Nitin Bansal reiterated a ...
Hosted on MSN4h
SNY's Sarclisa Gets EU Nod for Expanded Use in Multiple Myeloma
Sanofi SNY announced that the European Commission (“EC”) has granted marketing authorization to expand the use of its multiple myeloma (MM) drug, Sarclisa (isatuximab). With this nod, Sarclisa is now ...
William Blair Issues Optimistic Estimate for BMY Earnings
Research analysts at William Blair upped their Q4 2024 earnings estimates for Bristol-Myers Squibb in a report released on Tuesday, January 21st. William Blair analyst M. Phipps now forecasts that the ...
Nuvalent: A First Look
Nuvalent, Inc. shares have fallen approximately 30% after promising updates on its two lead NSCLC candidates rallied the ...
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Stifel initiated coverage on Cytokinetics Incorporated (NASDAQ:CYTK), noting the company’s catalyst rich one to two years.
Is Bristol-Myers Squibb Company (BMY) the Best Stock to Invest In For Steady Dividends?
We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...